Shots:
- Otsuka and Click have reported the initiation of the Mirai study which is a fully remote clinical trial to investigate the effectiveness of digital therapeutics in reducing depressive symptoms in adults diagnosed with MDD who are on antidepressant monotherapy. The study will enroll ~540 patients globally
- The trial will run fully remotely utilizing the Verily Project Baseline platform, a first-of-its-kind trial design for MDD. Participation will be of 10wks. and efficacy will be evaluated as a change from baseline in the MADRS total score
- The companies’ collaboration with Verily enables the trial to proceed efficiently and safely during the pandemic
Click here to read full press release/ article | Ref: Businesswire | Image: Contract Pharma
The post Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder first appeared on PharmaShots.
